Gata6+ resident peritoneal macrophages promote the growth of liver metastasis

Mokarram Hossain1,2,3, Raymond Shim1,2, Woo-Yong Lee2

  • 1Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.

Nature Communications
|July 29, 2022
PubMed

Insights

Large peritoneal macrophages (GLPMs) promote liver metastasis growth by suppressing T cell function. Depleting GLPMs or blocking their PD-L1 pathway inhibits tumor progression and recurrence.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Resident macrophages are implicated in tumor progression.
  • Large peritoneal macrophages (GLPMs) reside near visceral organs but their role in cancer is unknown.
  • GLPMs can invade injured organs sensing danger signals.

Purpose of the Study:

  • To investigate the role of GLPMs in liver metastasis.
  • To understand the mechanisms by which GLPMs influence tumor growth and immune response.

Main Methods:

  • Depletion of GLPMs using pharmacological and genetic tools.
  • Analysis of GLPMs' interaction with tumor cells and immune cells.
  • Administration of anti-PD-L1 therapy via intraperitoneal and intravenous routes.
  • Assessment of tumor growth and recurrence after thermal ablation.

Main Results:

  • GLPMs infiltrate liver metastases by sensing ATP.
  • Depletion of GLPMs significantly reduces metastasis growth.
  • Tumor cell apoptotic bodies upregulate PD-L1 on GLPMs, inhibiting CD8+ T cell function.
  • Intraperitoneal anti-PD-L1 therapy reduces tumor growth, while intravenous administration is ineffective.
  • Thermal ablation of metastases increases GLPM recruitment, leading to tumor regrowth.

Conclusions:

  • GLPMs are critical drivers of liver metastatic growth and recurrence.
  • Targeting GLPMs, particularly via PD-L1 blockade locally, offers a potential therapeutic strategy.